David Fisher
Direttore/Membro del Consiglio presso NANOSONICS LIMITED
Patrimonio netto: 576 301 $ in data 30/04/2024
Posizioni attive di David Fisher
Società | Posizione | Inizio | Fine |
---|---|---|---|
NANOSONICS LIMITED | Direttore/Membro del Consiglio | 27/07/2009 | - |
Independent Dir/Board Member | 30/07/2001 | - | |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 1 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Direttore/Membro del Consiglio | - | - |
Australian Biomedical Fund No. 2 Ltd.
Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 2 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Direttore/Membro del Consiglio | - | - |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Australian Biotechnology & Healthcare Fund No. 3 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Direttore/Membro del Consiglio | - | - |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Corporate Officer/Principal | - | - |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investitore di Private Equity | 01/09/2006 | - |
Storia della carriera di David Fisher
Precedenti posizioni note di David Fisher
Società | Posizione | Inizio | Fine |
---|---|---|---|
AERIS ENVIRONMENTAL LTD | Direttore/Membro del Consiglio | 09/05/2011 | 01/07/2014 |
Presidente | 10/05/2011 | 29/03/2013 | |
GI Therapies Pty Ltd.
GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology GI Therapies Pty Ltd. designs and develops medical devices for the treatment of chronic constipation. It offers technology to treat gastrointestinal motility disorders, including chronic constipation, irritable bowel syndrome with constipation and gastroparesis. The company was founded in 2012 and is headquartered in Melbourne, Australia. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Direttore/Membro del Consiglio | - | - |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di David Fisher
The University of Sydney | Doctorate Degree |
Statistiche
Distribuzione geografica
Australia | 11 |
Giappone | 2 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 8 |
Chief Executive Officer | 2 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 6 |
Finance | 5 |
Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
NANOSONICS LIMITED | Health Technology |
AERIS ENVIRONMENTAL LTD | Consumer Non-Durables |
Aziende private | 9 |
---|---|
Arana Therapeutics Ltd.
Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Health Technology |
Signostics Ltd.
Signostics Ltd. Medical SpecialtiesHealth Technology Signostics Ltd. provides ultrasound devices. It offers Uscan and Signosrt Handheld Ultrasound scanner. The company was founded by Neil Bartlett and Stewart Bartlett in 2005 and is headquartered in Adelaide, Australia. | Health Technology |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 1 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Finance |
Australian Biomedical Fund No. 2 Ltd.
Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 2 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Finance |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Australian Biotechnology & Healthcare Fund No. 3 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Finance |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
GI Therapies Pty Ltd.
GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology GI Therapies Pty Ltd. designs and develops medical devices for the treatment of chronic constipation. It offers technology to treat gastrointestinal motility disorders, including chronic constipation, irritable bowel syndrome with constipation and gastroparesis. The company was founded in 2012 and is headquartered in Melbourne, Australia. | Health Technology |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
- Borsa valori
- Insiders
- David Fisher
- Esperienza